• 1. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrroles Phenylpyrroles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrroles Substituted pyrroles Phenylpyrroles

Comprehensive Overview of Atorvastatin Methyl Ester (CAS No. 345891-62-5): Properties, Applications, and Industry Insights

Atorvastatin Methyl Ester (CAS No. 345891-62-5) is a critical intermediate in the synthesis of atorvastatin, a widely prescribed statin for managing cholesterol levels. This compound has garnered significant attention in pharmaceutical research due to its role in optimizing the bioavailability and metabolic stability of the parent drug. With the growing global focus on cardiovascular health and preventive medicine, understanding the chemical and functional properties of Atorvastatin Methyl Ester is essential for researchers and manufacturers alike.

The structural uniqueness of Atorvastatin Methyl Ester lies in its esterified form, which enhances lipophilicity and facilitates easier penetration into cellular membranes. This modification is pivotal during the drug development process, as it allows for better control over the pharmacokinetic profile of atorvastatin. Recent studies highlight its utility in improving drug delivery systems, particularly in formulations targeting LDL cholesterol reduction—a key concern for patients with hyperlipidemia.

In the context of sustainability and green chemistry, the synthesis of Atorvastatin Methyl Ester has evolved to incorporate eco-friendly catalysts and reduced solvent waste. Innovations such as flow chemistry and enzymatic esterification are now being explored to align with the pharmaceutical industry’s push toward environmentally responsible manufacturing. These advancements address frequent search queries like "green synthesis of statin intermediates" and "sustainable pharmaceutical production."

From a commercial perspective, the demand for Atorvastatin Methyl Ester is driven by the expanding generics market and the rising prevalence of cardiovascular diseases. Analysts project steady growth for statin intermediates, fueled by aging populations and increasing health awareness. Searches for terms like "atorvastatin API suppliers" and "high-purity statin intermediates" reflect this trend, underscoring the need for reliable sourcing and stringent quality control.

Quality standards for Atorvastatin Methyl Ester (CAS No. 345891-62-5) are rigorously defined by pharmacopeias such as USP and EP. Impurity profiling, including the detection of process-related degradants, is a recurring topic in analytical forums. Advanced techniques like HPLC-MS and NMR spectroscopy are employed to ensure compliance with regulatory requirements, a subject often queried as "analytical methods for statin intermediates."

Future research on Atorvastatin Methyl Ester may explore its potential in combination therapies or novel formulations, such as nanoparticle-based delivery systems. With AI-driven drug discovery gaining traction, computational modeling of ester derivatives could accelerate the development of next-generation cholesterol-lowering agents. This aligns with trending searches like "AI in pharmaceutical synthesis" and "advanced drug formulation technologies."

• 125995-03-1(Atorvastatin lactone)
• 134395-00-9((bR,δR)-Atorvastatin tert-Butyl Ester (>90%))
• 581772-29-4(Atorvastatin Acetonide)
• 163217-74-1(1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-N-(2-hydroxyphenyl)-2-(1-methylethyl)-4-phenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-)
• 134523-00-5(Atorvastatin)
• 693794-20-6(Difluoro Atorvastatin)
• 908852-19-7(Methanamine (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)
• 110862-48-1(Atorvastatin)
• 163217-70-7(4-Hydroxy Atorvastatin Lactone)
• 265989-36-4(4-Hydroxy Atorvastatin Acetonide tert-Butyl Ester)